Abzena is proud to be the lead partner for World ADC Asia 2024, taking place in Incheon, South Korea, on June 25–27. 

Visit us at booth #9.

Meet with Ji-won Chio, Senior Director, Client Engagement, or Jonathan Cruickshank, Head of EU/ROW Sales, and learn how utilizing our expertise in identifying and mapping the appropriate design space for the development of your complex Antibody Drug Conjugates (ADC) can accelerate lead drug candidate selection, as well as how we can identify and de-risk your clinical candidates for development and ensure stage-specific milestones are met through our developability assessments.

Don’t miss our talk on day 1 at 9:30 AM given by Petra Dieterich, PhD.